Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.57 USD | +0.13% | -5.72% | +63.08% |
May. 20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
May. 14 | Enliven Therapeutics Q1 Loss Narrows | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 24.70 | 24.70 | 23.94 |
Spread/Res. | -8.62% | -8.62% | -5.72% |
Spread/Supp. | +10.58% | +34.51% | +41.24% |
Support | 20.41 | 16.78 | 15.98 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ELVN Stock
- Charts Enliven Therapeutics, Inc.